top of page


impairED glUCoSe TolerANCE
It is estimated that 7.5% of the global population have Impaired Glucose Tolerance (IGT), which is an intermediate metabolic state of abnormal glucose regulation that stands between healthy blood glucose levels and diabetes.
Over an observational period of 3 – 5 years, it is shown that 25% of those with IGT progress into diabetes, 50% remaining in their abnormal glycemic state, and 25% reverting to normal glucose levels [1],[2],[3].
Since symptoms of IGT are often mild or non-existent, blood testing for IGT is suggested as a measure of the severity.
Glucose levels can be tested 3 ways:
-
Fasting blood glucose, via blood
-
2-hour blood sugar, breath test
-
HbA1C, blood test
It is important to account for blood sugar levels fluctuating depending on the biological state of your body on that given day. Therefore a normal fasting glucose does not necessarily rule out IGT. For a more accurate determinant on blood sugar regulation, the HbA1c test averages out your blood sugar levels over a period of 90 days, providing the most appropriate measure [4].
Normal glucose levels are as follows :
-
Fasting blood sugar: Less than 5.6 mmol/L
-
2-hour blood sugar : Less than 7.8 mmol/L
-
HbA1C : Less than 5.7
Impaired Glucose Tolerance levels are as follows :
-
Fasting blood sugar: Over 5.6 mmol/L
-
2-hour blood sugar : Over 7.8 mmol/L
-
HbA1C : 5.7 - 6.4.
-
Note: HbA1c, over 6.4 indicates diabetes [5].
signs & symptoms
Depending on the severity and duration of IGT symptoms vary from subtle to more severe, the symptoms below are listed in order of subtlest to more severe cases.
Carbohydrate Cravings
-
Urge for sweet or starchy foods
In individuals with impaired glucose tolerance, when glucose levels drop rapidly after a spike, the brain, particularly glucose-sensing neurons in the hypothalamus, detects this decline and activates compensatory pathways to restore energy balance.
This process stimulates the autonomic nervous system and the release of counter-regulatory hormones such as adrenaline and cortisol, which heighten hunger and the drive to seek quick sources of glucose. Research demonstrates that during experimentally induced hypoglycaemia, food cravings increased more than 4 fold, with the strongest urges directed toward high-carbohydrate foods.
This occurs because glucose is the brain’s principal energy substrate, and low circulating glucose levels impair neuronal function, prompting an adaptive response to rapidly replenish it. Consequently, people with IGT experience greater post-meal glucose swings and reactive hypoglycaemia often develop cravings for sweet or starchy foods. [64]
Localised Abdominal Weight
Research shows IGT doesn’t just make it harder for the body to use sugar properly, it also changes where fat is stored. Large genetic studies have found that people who are more prone to poor glucose metabolism tend to carry extra weight around the waist and belly, even if their overall body weight isn’t very high.
This happens because when the body stops responding well to insulin, the fat under the skin doesn’t store energy as effectively, so more fat ends up being deposited deeper in the abdomen, around the organs. Studies confirm this link, showing that genes connected to insulin resistance ( poor sugar metabolism ) also encourage central fat gain. [54][55]
Energy Depletion Associated with Missed Meals
-
Faintness
-
Dizziness
-
Trembling or weakness
In IGT, the body's cells do not respond optimally to insulin, which causes glucose levels to elevate within the blood. In this circumstance, the body attempts to compensate by prolonging the secretion of insulin in order to lower the elevated blood sugar levels. This sustained hyperinsulinaemic response can precipitate a significant decline and exaggerated drop in blood glucose many hours after consuming the meals. This level of decline can manifest as sensations of faintness or dizziness when missing a meal, or on the upper end trembling and weakness [6].
Xerosis and Ichthyosiform - Dry Skin + Cracked Heels
-
Very dry or scaly skin on the lower legs, feet and hands
-
Cracked Heels
Dry skin (xerosis) and fish-scale-like skin (ichthyosiform changes) are very common in people with poor sugar control, affecting around 40% of patients overall. These changes usually appear on the lower legs and feet, and less often on the hands.
It occurs because diabetes can damage small nerves that control sweating, leading to reduced moisture in the skin. Over time, poor circulation and the buildup of sugar-damaged proteins, known as advanced glycation end-products further weaken the skin’s barrier, slowing natural cell renewal. As a result, the skin becomes dry, rough, and scaly. [61]
Poor blood sugar control also contributes to cracked heels through several structural and biochemical skin changes, which cause collagen fibers in the skin to stiffen and lose elasticity. This, combined with reduced hydration of the stratum corneum results in drier, less flexible skin that is prone to cracking, particularly on pressure-bearing areas such as the heels. This is further demonstrated in research which has highlighted 92 - 100% of diabetic participants exhibited some form of heel skin cracking. [68]
Recurring Infections
-
Urinary Tract Infections
-
Oral Candidiasis
-
Vaginal Candidiasis
-
Fungal Nail Infection
Poor glucose regulation, as in impaired glucose tolerance or diabetes is strongly associated with recurrent infections, notably yeast and urinary-tract infections. Elevated blood glucose creates multiple converging problems, firstly it feeds yeasts and bacteria directly via increased sugar in saliva, urine and mucosal secretions. It also impairs immune cell function and micro-circulation, and in the urinary tract it promotes microbial growth and retention of infected urine.
In one study comparing 15 studies of 827,948 participants, UTI prevalence was estimated to be 11.5% higher in those with poor sugar metabolism in contrast to healthy controls. [59]
In parallel, those with high blood-sugar levels have a markedly higher incidence of yeast and fungal infections. Studies have demonstrated that in people with diabetes or impaired glucose tolerance, Candida colonisation occurs far more frequently than in the general population, with oral candidiasis affecting approximately 68 - 84 % of diabetic individuals compared with only 27 % of non-diabetics.
Vaginal candidiasis shows a similarly higher burden, with 18.8 % of women with type 2 diabetes infected versus 11.8 % in healthy controls, and recurrence rates markedly higher when HbA₁c levels exceed 8 %.
Furthermore skin and nail infections such as fungal nails are present in up to 84 % of diabetics with peripheral neuropathy or vascular compromise, which is about 2.5 times the rate seen in non-diabetic populations. [60]
Anxiety Symptoms
25% increased risk of anxiety symptoms including:
-
Racing thoughts
-
Scattered thoughts
-
Hypervigilance
-
Overwhelm
-
Irritability
-
Impatience
-
Restlessness
Impaired glucose metabolism contributes to heightened anxiety risk through both physiological and neurochemical mechanisms. Fluctuating or chronically elevated blood glucose levels activate the hypothalamic–pituitary–adrenal (HPA) axis, increasing the release of stress hormones such as cortisol and adrenaline, which in turn stimulate sympathetic nervous system activity, reinforcing anxious arousal and anxiety symptoms.
Supporting this, a large systematic review of 12 studies and 12,626 individuals with impaired glucose control, found individuals were 25% more likely to experience anxiety symptoms than non-diabetic controls. [65]
Depressive Symptoms
35% increased risk of depressive symptoms
-
Sadness
-
Pessimism / Negativity
-
Loss of pleasure
Persistently elevated glucose levels trigger systemic inflammation, increasing proinflammatory cytokines which interfere with serotonin synthesis. This has been clinically demonstrated in a review of 24 independent papers examining the relationship between blood-sugar regulation and depression. The results demonstrated individuals with poor glucose control and subsequent high blood sugar are significantly more likely to experience depression than those with normal glucose levels, with an approximate prevalence of 35%. [66]
Neuropathy of the Hands and Feet
-
Pins and Needles
-
Burning Sensation or Pain
-
Numbness - Advanced stages
Long-term high blood sugar damages the small blood vessels that supply nerves, especially in the feet and hands. Over time, this causes a loss of nerve function, particularly in the sensory nerves. This can manifest as first feel burning, tingling like pins and needles, or pain in the hands and feet particularly at night or on during rest, and in more advanced stages numbness or loss of sensation can occur. It is estimated that 40% of neuropathy cases are associated with having IGT [7][8][53]
Skin Tags
Skin tags are small, benign skin growths often found on the neck, under the breasts, armpits, eye lid area, or thighs and groin, and can serve as a visible clue to IGT. Research shows that elevated insulin levels as the result of poor sugar metabolism can stimulate growth factor-receptors such as the insulin-like growth factor-1 receptor (IGF-1R) in skin fibroblasts and keratinocytes, which promotes local proliferation of skin cells and the formation of tags. [56]
Moreover, the presence of multiple skin tags strongly correlates with the measures of poor sugar control. In one study, individuals with multiple tags had substantially higher odds of insulin resistance / IGT, compared to those without, often in the 40 - 70% higher probability range. [57]
Cognitive impairments
-
Memory Decline
-
Poor word recall
Cognitive impairments can be described as a decline in cognitive abilities such as concentration, memory, and verbal fluency. While the brain was traditionally thought to be insulin-insensitive, recent research indicates that poor insulin sensitivity associated with Impaired Glucose Tolerance plays a role in cognitive health [10].
One study following participants with Impaired Glucose Tolerance for 2 - 4 years showed a significant association with memory decline [11]. Another study which administered insulin intranasally for 8 weeks demonstrated a significantly higher word recall in participants, and even reflected enhanced mood and confidence [12].
Impaired glucose metabolism to varying degrees is associated with decrements in cognitive function and changes in brain structure, with the extent of type 2 diabetes being associated with a 50% increased risk of developing dementia [13].
Eye Discomfort + Visual Disturbances
-
Eye Strain or Pressure
-
Blurred close-up focus after sugar rich foods
Poor sugar metabolism and excess glucose in the bloodstream draws fluid into and out of the eye’s lens and retinal tissues, temporarily changing its shape and thickness. This process alters how light is focused, leading to blurry or shifting vision that can come and go as glucose levels significantly increase and decrease.
Over time, chronically elevated glucose can damage the tiny blood vessels that supply the retina, leading to reduced oxygen delivery and retinal thinning, especially in the outer nuclear and photoreceptor layers. Studies using retinal imaging show that even people with prediabetes can develop subtle retinal structural changes and visual disturbances before diabetes is diagnosed.
These early visual altercations can manifest as sensations of eye strain or eye pressure. It can also manifest itself as a fluctuating of focus, with temporary blurred vision, particularly close up objects and after consuming high sugar meals. [14][15]
High Blood Pressure
Insulin resistance, a core feature of impaired glucose tolerance, contributes to increased blood pressure through multiple interlinked mechanisms. Chronically elevated insulin levels stimulate the sympathetic nervous system (SNS) and the renin-angiotensin-aldosterone system (RAAS), promoting sodium and water retention, increasing plasma volume, whilst also inducing vasoconstriction, all of which increase blood pressure.
Clinically, this pathway has been demonstrated in large studies, as an example a study of 8,513 adults with hypertension demonstrated that those who tested positive in the highest quartile for insulin resistance had a 49% higher odds of uncontrolled hypertension compared to the lowest quartile of insulin resistant / IGT participants. [67]
Polycystic ovarian syndrome - PCOS
IGT can lead to excessive production of the hormone insulin, known as hyperinsulinemia. Hyperinsulinemia can play a pivotal role in the aetiology of PCOS as increasing insulin drives excessive ovarian testosterone production and lowers the circulating amount of sex hormone-binding globulin (SHBG) and promotes free testosterone, which constrains follicle formation resulting in irregular menstrual cycles [16].
It is important to note that while obesity plays an important role in these metabolic features, defective insulin sensitivity and secretion is also present in lean PCOS patients [17].
Causes
Insulin Resistance
Moderate to Severe Insulin Resistance is a hallmark of IGT. Insulin Resistance is when the body cannot effectively use insulin, a hormone produced by the pancreas that regulates blood sugar levels. Insulin helps glucose enter the cells of the body, where it is used for energy. When the body becomes resistant to insulin, glucose remains in the bloodstream, leading to high blood sugar levels.
The underlying cause of this insulin resistance appears predominantly to be inflammation. The primary suspects appear to be inflammatory mediators including the inflammatory cytokine tumor necrosis factor alpha (TNFα) as well as inflammatory protein kinases such as c-JUN N-terminal kinase (JNK) and the IKK complex [18].
Abdominal weight
There is a direct link between abdominal weight and the development of IGT. Abdominal fat is thought to increase the risk of IGT, as the fatty tissue increases the secretion of adipocytokines including tumour necrosis factor-α, which negatively affects insulin sensitivity.
It is shown that reductions in waist circumference are associated with an improvement in lower levels of adipose tissue secreted factors, which thereby improves the ability of insulin to transport and deliver glucose to the cell [19]. This is because excess fat intake and body weight make the body less sensitive to insulin.
High Cortisol
Cortisol, a hormone produced in conditions of both stress and inflammation is a key player in activating enzymes responsible for processes of gluconeogenesis. Gluconeogenesis is where glucose is produced from non-carbohydrate sources, such as protein and fatty acids, thereby chronically elevating blood sugar levels [20].
Beyond this, Chronic elevated cortisol is directly linked to making insulin less effective in muscle tissue, but in fat tissue insulin works better, encouraging the growth of more fat cells, which is linked to insulin resistance.
Cortisol also triggers the release of free fatty acids into the bloodstream, which can then interfere with the action of insulin, making it harder for cells to absorb sugar from the blood, all contributing to IGT [21]. To note medications such as steroids are aligned with these responses [22].
Chronic Infections + Inflammation
-
Hepatic Insufficiency
-
SIBO
-
Candiasis
-
Epstein Barr
-
Herpes Simplex
-
MSK Inflammation
-
Tregs Dysfunction - Autoimmunity
-
Mast Cell Activation
During infections or states of chronic inflammation, cytokines which are chemical messengers are released, commonly including TNF-α, IL-6, and IL-1β. These cytokines interfere with insulin’s normal action by disrupting the cell-surface insulin receptor signalling cascade. Specifically, they promote serine phosphorylation of insulin-receptor substrate (IRS) proteins and activate intracellular pathways including JNK and NF-κB, resulting in inhibition of insulin signalling and reduced glucose uptake by cells, even in the presence of normal insulin levels. [62]
Pancreatic beta-cell loss or functional deficiency
Within the pancreas are beta-cells, these pancreatic beta-cells play a crucial key role in glucose homeostasis by secreting insulin in response to blood glucose concentrations [23].
Studies reflect that a functional deficiency in pancreatic beta-cells and/or a loss of beta-cell secretory function can be an important driver for impaired secretion of insulin and subsequent development of IGT [24].
Palmitic Acid
Blood that contains an abnormal elevation of lipid fats is strongly associated with metabolic dysfunctions such as IGT, with recent studies consistently reporting a 35 - 50% prevalence of dyslipidaemia in type 2 diabetes [17].
In particular the fatty acid Palmatic acid is largely at play. Clinical studies have demonstrated Palmatic acid to be destructive to the pancreatic beta-cells responsible for insulin secretion. It does this by increasing oxidative stress, and lowering the natural defenses, like SOD2. As well as causing stress in the endoplasmic reticulum, a part of the cell that helps fold proteins. Also by triggering inflammatory proteins such as IL-6 and IL-8, and by promoting cell death (apoptosis), by activating a protein called CHOP, which pushes cells toward self-destruction [25],[26].
Gut Dysbiosis + Intestinal Permeability
When the gut microbiome is in a dysbiotic state, there may be an increase in the number of Gram-negative bacteria. This kind of bacteria produces Lipopolysaccharides (LPS) as it is found in their outer membrane.
LPS are associated with increased gut permeability, allowing bacteria and bacterial fragments to pass into the bloodstream, known as endotoxemia.
Chronic endotoxemia activates a chronic low-grade inflammatory response and high concentrations of TMAO produced by the liver, which are key factors in the development of insulin resistance and subsequent IGT.
Beyond this beneficial bacteria are associated with increased production of short-chain fatty acids (SCFAs). Reduced levels of SCFAs in the intestine are associated with decreased secretion of the intestinal hormones GLP-1 and PYY, which subsequently negatively affect insulin secretion and glucose metabolism [27],[28].
Menopause
Menopause is associated with a disposition towards IGT, primarily due to the decline in estrogen levels, as estrogen supports insulin sensitivity. This hormonal shift, along with other factors like changes in body composition lead to a decline in the body's ability to effectively use insulin, thereby affecting glucose metabolism [29],[30].
References
[1] https://www.ncbi.nlm.nih.gov/books/NBK11923/
[2] https://www.ncbi.nlm.nih.gov/books/NBK499910/
[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC8026645/
[4].https://www.ncbi.nlm.nih.gov/books/NBK549816/#:~:text=Introduction,indicator%20of%20blood%20sugar%20control
[5].https://diabetesjournals.org/care/article/30/3/753/25705/Impaired-Fasting-Glucose-and-Impaired-Glucose
[6].https://www.openaccessjournals.com/articles/significance-of-impaired-glucose--tolerance-and-its-treatment-options-16180.html
[7] https://pubmed.ncbi.nlm.nih.gov/18195653/
[8].https://www.openaccessjournals.com/articles/significance-of-impaired-glucose--tolerance-and-its-treatment-options-16180.html
[9].https://www.openaccessjournals.com/articles/significance-of-impaired-glucose--tolerance-and-its-treatment-options-16180.html
[10] https://pubmed.ncbi.nlm.nih.gov/25414013/
[11] https://pubmed.ncbi.nlm.nih.gov/33203727/
[12] https://pubmed.ncbi.nlm.nih.gov/15288712/
[13] https://pmc.ncbi.nlm.nih.gov/articles/PMC4837888/
[14].https://www.openaccessjournals.com/articles/significance-of-impaired-glucose--tolerance-and-its-treatment-options-16180.html
[15] https://pmc.ncbi.nlm.nih.gov/articles/PMC8548131/
[16].https://pmc.ncbi.nlm.nih.gov/articles/PMC9665922/
[17] https://www.metagenicsinstitute.com.au/tech-data/cocoa-cinnamon-chromium-metabolic
[18] https://pmc.ncbi.nlm.nih.gov/articles/PMC4587882/
[19].https://pmc.ncbi.nlm.nih.gov/articles/PMC2658023/
[20] https://www.ncbi.nlm.nih.gov/books/NBK538239/
[21].https://pmc.ncbi.nlm.nih.gov/articles/PMC3942672/
[22] https://pmc.ncbi.nlm.nih.gov/articles/PMC4587882/
[23].https://pmc.ncbi.nlm.nih.gov/articles/PMC5866358/
[24] https://pubmed.ncbi.nlm.nih.gov/25697093/
[25] https://pubmed.ncbi.nlm.nih.gov/14561212/
[26] https://pmc.ncbi.nlm.nih.gov/articles/PMC8983927/
[27].https://www.sciencedirect.com/science/article/pii/S2666149724000483
[28].https://www.sciencedirect.com/science/article/pii/S2666149724000483
[29] https://pmc.ncbi.nlm.nih.gov/articles/PMC6341301/
[30].https://gremjournal.com/journal/02-03-2023/metabolic-syndrome-insulin-resistance-and-menopause-the-changes-in-body-structure-and-the-therapeutic-approach/
[31] https://pubmed.ncbi.nlm.nih.gov/19734396/
[32] https://pubmed.ncbi.nlm.nih.gov/25168916/
[33] https://pmc.ncbi.nlm.nih.gov/articles/PMC10679383/
[34].https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1528383/full
[35] https://pubmed.ncbi.nlm.nih.gov/9541169/
[36].https://www.sciencedirect.com/science/article/pii/S092422442300331X
[37] https://pmc.ncbi.nlm.nih.gov/articles/PMC4153083/
[38] https://pmc.ncbi.nlm.nih.gov/articles/PMC8212206/
[39].https://www.sciencedirect.com/science/article/pii/S0925443922001478
[40] https://pubmed.ncbi.nlm.nih.gov/37290429/
[41] https://www.nature.com/articles/nrendo.2015.128
[42] https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/
[43] https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/#en1
[44] https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/
[45] https://pubmed.ncbi.nlm.nih.gov/15208835/
[46] https://pmc.ncbi.nlm.nih.gov/articles/PMC9824456/
[47].https://pmc.ncbi.nlm.nih.gov/articles/PMC9578061/#:~:text=Pooled%20results%20from%20the%20random,not%20affect%20LDL%20cholesterol%20concentration.
[48] https://pmc.ncbi.nlm.nih.gov/articles/PMC9824456/
[49] https://lpi.oregonstate.edu/mic/dietary-factors/lipoic-acid
[50] https://pmc.ncbi.nlm.nih.gov/articles/PMC2410097/
[51].https://www.metagenicsinstitute.com.au/tech-data/indian-barberry-and-milk-thistle-for-blood-glucose-metabolism-and-liver-function-support
[52] https://www.tuscany-diet.net/lipids/fatty-acids/palmitic-acid/
[53] https://www.ncbi.nlm.nih.gov/books/NBK442009/
[54].https://genepi.qimr.edu.au/contents/p/staff/Shungin_Nature_Feb2015EPUB.pdf
[55].https://www.cambridge.org/core/services/aop-cambridge-core/content/view/B61DBCD0C1A42FBDA20B298F9D113E9F/S1369052300000775a.pdf/
[56].https://bmcdermatol.biomedcentral.com/articles/10.1186/s12895-020-00111-0
[57] https://pubmed.ncbi.nlm.nih.gov/20464083/
[58].https://www.frontiersin.org/journals/urology/articles/10.3389/fruro.2023.1275334/full
[59].https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-022-00644-9
[60] https://pmc.ncbi.nlm.nih.gov/articles/PMC6352194/
[61] https://www.ncbi.nlm.nih.gov/books/NBK481900/
[62] https://link.springer.com/article/10.1007/s43152-024-00056-3
[63] https://pubmed.ncbi.nlm.nih.gov/20452076/
[64] https://pubmed.ncbi.nlm.nih.gov/14984802/
[65] https://www.sciencedirect.com/science/article/abs/pii/S0022399912003339
[66] https://pubmed.ncbi.nlm.nih.gov/10895843/
[67] https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-02038-5
[68].https://www.sciencedirect.com/science/article/pii/S0965206X19300828
bottom of page